BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38042497)

  • 21. Dose-volume parameters predict radiation pneumonitis after induction chemoradiotherapy followed by surgery for non-small cell lung cancer: a retrospective analysis.
    Katsui K; Ogata T; Watanabe K; Katayama N; Soh J; Kuroda M; Kiura K; Maeda Y; Toyooka S; Kanazawa S
    BMC Cancer; 2019 Nov; 19(1):1144. PubMed ID: 31771538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic Radiation Pneumonitis in NSCLC Patients Receiving EGFR-TKIs and Concurrent Once-daily Thoracic Radiotherapy: Predicting the Value of Clinical and Dose-volume Histogram Parameters.
    Yang X; Mei T; Yu M; Gong Y
    Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):409-419. PubMed ID: 35747920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and Dosimetric Factors Predicting Grade ≥2 Radiation Pneumonitis After Postoperative Radiotherapy for Patients With Non-Small Cell Lung Carcinoma.
    Boonyawan K; Gomez DR; Komaki R; Xu Y; Nantavithya C; Allen PK; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):919-926. PubMed ID: 29976504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicting pneumonitis risk: a dosimetric alternative to mean lung dose.
    Tucker SL; Mohan R; Liengsawangwong R; Martel MK; Liao Z
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):522-7. PubMed ID: 22580121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive parameters of symptomatic radiation pneumonitis following stereotactic or hypofractionated radiotherapy delivered using volumetric modulated arcs.
    Bongers EM; Botticella A; Palma DA; Haasbeek CJ; Warner A; Verbakel WF; Slotman B; Ricardi U; Senan S
    Radiother Oncol; 2013 Oct; 109(1):95-9. PubMed ID: 24183862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose thoracic radiation therapy for non-small cell lung cancer: a novel grading scale of radiation-induced lung injury for symptomatic radiation pneumonitis.
    Szejniuk WM; Nielsen MS; Takács-Szabó Z; Pawlowski J; Al-Saadi SS; Maidas P; Bøgsted M; McCulloch T; Frøkjær JB; Falkmer UG; Røe OD
    Radiat Oncol; 2021 Jul; 16(1):131. PubMed ID: 34266462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiation pneumonitis after definitive concurrent chemoradiotherapy with cisplatin/docetaxel for non-small cell lung cancer: Analysis of dose-volume parameters.
    Katsui K; Ogata T; Watanabe K; Katayama N; Kuroda M; Kiura K; Hiraki T; Maeda Y; Toyooka S; Kanazawa S
    Cancer Med; 2020 Jul; 9(13):4540-4549. PubMed ID: 32364685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning.
    Wang W; Xu Y; Schipper M; Matuszak MM; Ritter T; Cao Y; Ten Haken RK; Kong FM
    Int J Radiat Oncol Biol Phys; 2013 Aug; 86(5):956-63. PubMed ID: 23845844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung.
    Baker R; Han G; Sarangkasiri S; DeMarco M; Turke C; Stevens CW; Dilling TJ
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):190-5. PubMed ID: 22929858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans.
    Tomita N; Kodaira T; Matsuo M; Furutani K; Tachibana H; Daimon T; Shimizu H
    Technol Cancer Res Treat; 2010 Aug; 9(4):407-15. PubMed ID: 20626206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Pneumonitis After Conventionally Fractionated Radiotherapy for Locally Advanced Lung Cancer.
    McFarlane MR; Hochstedler KA; Laucis AM; Sun Y; Chowdhury A; Matuszak MM; Hayman J; Bergsma D; Boike T; Kestin L; Movsas B; Grills I; Dominello M; Dess RT; Schonewolf C; Spratt DE; Pierce L; Paximadis P; Jolly S; Schipper M;
    Int J Radiat Oncol Biol Phys; 2021 Dec; 111(5):1176-1185. PubMed ID: 34314815
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric definitions of total lung volumes in calculating parameters predictive for radiation-induced pneumonitis.
    Kabolizadeh P; Kalash R; Huq MS; Greenberger JS; Heron DE; Beriwal S
    Am J Clin Oncol; 2015 Aug; 38(4):401-4. PubMed ID: 24064747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric factors used for thoracic X-ray radiotherapy are not predictive of the occurrence of radiation pneumonitis after carbon-ion radiotherapy.
    Koto M; Tsujii H; Yamamoto N; Nishimura H; Yamada S; Miyamoto T
    Tohoku J Exp Med; 2007 Oct; 213(2):149-56. PubMed ID: 17917408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
    Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The incidence of and risk factors for radiation pneumonitis in patients treated with simultaneous bevacizumab and thoracic radiotherapy.
    Chen F; Niu J; Wang M; Zhu H; Guo Z
    Radiat Oncol; 2024 May; 19(1):67. PubMed ID: 38816745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiation pneumonitis after concurrent aumolertinib and thoracic radiotherapy in EGFR-mutant non-small cell lung cancer patients.
    Yin H; Jia W; Yu J; Zhu H
    BMC Cancer; 2024 Feb; 24(1):197. PubMed ID: 38347438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer.
    Yang J; Xu T; Gomez DR; Yuan X; Nguyen QN; Jeter M; Song Y; Hahn S; Liao Z
    Oncotarget; 2017 Jun; 8(26):43080-43090. PubMed ID: 28574846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Barriger RB; Forquer JA; Brabham JG; Andolino DL; Shapiro RH; Henderson MA; Johnstone PA; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):457-62. PubMed ID: 21035956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy.
    Liu H; Zhang X; Vinogradskiy YY; Swisher SG; Komaki R; Chang JY
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):1017-23. PubMed ID: 22543216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severity of radiation pneumonitis, from clinical, dosimetric and biological features: a pilot study.
    Aso S; Navarro-Martin A; Castillo R; Padrones S; Castillo E; Montes A; Martínez JI; Cubero N; López R; Rodríguez L; Palmero R; Manresa F; Guerrero T; Molina M
    Radiat Oncol; 2020 Oct; 15(1):246. PubMed ID: 33109238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.